Correlation Between Scpharmaceuticals and LENZ Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and LENZ Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and LENZ Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and LENZ Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and LENZ Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of LENZ Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and LENZ Therapeutics.
Diversification Opportunities for Scpharmaceuticals and LENZ Therapeutics
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Scpharmaceuticals and LENZ is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and LENZ Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LENZ Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with LENZ Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LENZ Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and LENZ Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and LENZ Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 19.36 times less return on investment than LENZ Therapeutics. In addition to that, Scpharmaceuticals is 1.05 times more volatile than LENZ Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. LENZ Therapeutics is currently generating about 0.2 per unit of volatility. If you would invest 1,508 in LENZ Therapeutics on August 30, 2024 and sell it today you would earn a total of 2,222 from holding LENZ Therapeutics or generate 147.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. LENZ Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| LENZ Therapeutics |
Scpharmaceuticals and LENZ Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and LENZ Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and LENZ Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, LENZ Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENZ Therapeutics will offset losses from the drop in LENZ Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| LENZ Therapeutics vs. Ikena Oncology | LENZ Therapeutics vs. Eliem Therapeutics | LENZ Therapeutics vs. HCW Biologics | LENZ Therapeutics vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |